Skip to content

Effect of two-stage goal-directed fluid therapy filled with crystalloid or colloid on postoperative quality of recovery in patients undergoing laparoscopic hepatectomy : A randomized controlled trial

Effect of two-stage goal-directed fluid therapy filled with crystalloid or colloid on postoperative quality of recovery in patients undergoing laparoscopic hepatectomy : A randomized controlled trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400087179
Enrollment
Unknown
Registered
2024-07-22
Start date
2024-07-25
Completion date
Unknown
Last updated
2024-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver disease

Interventions

Group P:goal-directed crystalloid solution
Group P:goal-directed colloid solution

Sponsors

Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Meet the indications of laparoscopic liver resection ; 2.Aged 18-65 years old ; 3.ASA grade I-III ; 4.Child-pugh grade A or B;

Exclusion criteria

Exclusion criteria: 1.known allergy to HES; 2.coagulation disorders (activated partial thromboplastin time greater than 1.5 times normal value); 3.preoperative renal insufficiency (serum creatinine greater than 2 mg/dl, oliguria, anuria, or hemodialysis); 4.cardiac arrhythmias; 5.estimated ejection fraction <35%; 6.severe chronic obstructive pulmonary disease (Stage 4); 7.Patients who received liver surgery

Design outcomes

Primary

MeasureTime frame
QoR-15 recovery quality scale;

Secondary

MeasureTime frame
NRS pain quality score;First exhaust time;Nausea and vomiting score;intraoperative blood loss;Main complications 30 days after operation;Secondary complications 30 days after operation;Occurrence of acute kidney injury;The time of getting out of bed and hospitalization;Total bilirubin;direct bilirubin;Glutamic pyruvic transaminase;glutamic-oxalacetic transaminase;Creatinine;Blood urea nitrogen;Occurrence frequency and duration of hypotension;Lactic acid;Glucose;Central venous oxygen saturation;Intraoperative hemodynamics;The use of vasoactive drugs;Surgery and anesthesia time, time of clamping porta hepatis, awakening time, extubation time, PACU stay time;SVV, SVI, CI, CVP;The amount of crystal and colloid used during operation;

Countries

China

Contacts

Public ContactDunyi Qi

Affiliated Hospital of Xuzhou Medical University

9472540@qq.com+86 180 5226 8338

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026